International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지

Apoptotic Effects of A Cisplatin and Eugenol Co-treatment of G361 Human Melanoma Cells

  • Park, Jun-Young (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Jo, Jae-Beom (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kim, In-Ryoung (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kim, Gyoo-Cheon (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Kwak, Hyun-Ho (Department of Oral Anatomy, School of Dentistry, Pusan National University) ;
  • Park, Bong-Soo (Department of Oral Anatomy, School of Dentistry, Pusan National University)
  • Received : 2011.07.19
  • Accepted : 2011.09.02
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Eugenol (4-allyl-2-methoxyphenol) is a naturally occurring phenolic compound that is widely used in dentistry as a component of zinc oxide eugenol cement that is commonly applied to the mouth environment. Cisplatin is one of the most potent known anticancer agents and shows significant clinical activity against a variety of solid tumors. This study was undertaken to investigate the synergistic apoptotic effects of co-treatments with eugenol and cisplatin on human melanoma (G361) cells. To investigate whether this co-treatment efficiently reduces the viability of G361 cells compared with each single treatment, an MTT assay was conducted. The induction and augmentation of apoptosis were confirmed by DNA electrophoresis, Hoechst staining and an analysis of DNA hypoploidy. Western blot analysis and immunofluorescent staining were also performed to evaluate the expression levels and the translocation of apoptosis-related proteins following this co-treatment. Furthermore, proteasome activity and mitochondrial membrane potential (MMP) changes were also assayed. The results indicated that a co-treatment with eugenol and cisplatin induced multiple pathways and processes associated with an apoptotic response in G361 cells including nuclear condensation, DNA fragmentation, a reduction in MMP and proteasome activity, the increase and decrease of Bax and Bcl-2, a decreased DNA content, the release of cytochrome c into the cytosol, the translocation of AIF and DFF40 (CAD) into the nucleus, and the activation of caspase-9, caspase-7, caspase-3, PARP and DFF45 (ICAD). In contrast, separate treatments of 300 ${\mu}M$ eugenol or 3 ${\mu}M$ cisplatin for 24 h did not induce apoptosis. Our present data thus suggest that a combination therapy of eugenol and cisplatin is a potential treatment strategy for human melanoma.

Keywords

References

  1. Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X, Akey CW. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol Cell. 2002;9:423-32. https://doi.org/10.1016/S1097-2765(02)00442-2
  2. Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Sved DN, Afaq F, Pasha FS, Saleem M, Mukhata H. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both invitro and in vivo. Clin Cancer Res. 2007;13:1611-9. https://doi.org/10.1158/1078-0432.CCR-06-2269
  3. Cheng AC, Jian CB, Huang YT, Lai CS, Hsu PC, Pan MH. Induction of apoptosis by Uncaria tomentosa through reactive oxygen species production, cytochrome c release, and caspases activation in human leukemia cells. Food Chem Toxicol. 2007;45:2206-18. https://doi.org/10.1016/j.fct.2007.05.016
  4. Cooley ME, Davis LE, DeStefano M, Abrahm J. Cisplatin: a clinical review. Part I--Current uses of cisplatin and administration guidelines. Cancer Nurs. 1994;17:173-84.
  5. Dattner AM. Herbal and complementary medicine in dermatology. Dermatol Clin. 2004;22:325-32.
  6. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J. 2000;14:729-39. https://doi.org/10.1096/fasebj.14.5.729
  7. Del Bello B, Valentini MA, Comporti M, Maellaro E. Cisplatininduced apoptosis in melanoma cells: role of caspase-3 and caspase-7 in Apaf-1 proteolytic cleavage and in execution of the degradative phases. Ann N Y Acad Sci. 2003;1010:200-4. https://doi.org/10.1196/annals.1299.034
  8. Drexler HC, Risau W, Konerding MA. Inhibition of proteasome function induces programmed cell death in proliferating endothelial cells. FASEB J. 2000;14:65-77. https://doi.org/10.1096/fasebj.14.1.65
  9. Fox SA, Kusmiaty, Loh SSW, Dharmarajan AM, Garlepp MJ. Cisplatin and TNF-alpha downregulate transcription of BclxL in murine malignant mesothelioma cells. Biochem Biophys Res Commun. 2005;337:983-91. https://doi.org/10.1016/j.bbrc.2005.09.147
  10. Gaqnon V, Van Themsche C, Turner S, Leblanc V, Asselin E. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Apoptosis. 2008;13:259-71. https://doi.org/10.1007/s10495-007-0165-6
  11. Garcia-Berrocal JR, Nevado J, Ramirez-Camacho R, Sanz R, Gonzalez-Garcia JA, Sanchez-Rodriguez C, Cantos B, Espana P, Verdaguer JM, Trinidad Cabezas A. The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear. Br J Pharmacol. 2007;152:1012-20.
  12. Golab J, Stoklosa T, Czajka A, Dabrowska A, Jakobisiak M, Zagozdzon R, Wojcik C, Marczak M, Wilk S. Synergistic antitumor effects of a selective proteasome inhibitor and TNF in mice. Anticancer Res. 2000;20:1717-21.
  13. Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatininduced cell death always produced by apoptosis? Mol Pharmacol. 2001;59:657-63. https://doi.org/10.1124/mol.59.4.657
  14. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-12. https://doi.org/10.1126/science.281.5381.1309
  15. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899- 911. https://doi.org/10.1101/gad.13.15.1899
  16. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Allyl Compounds, Aldehydes, Epoxides and Peroxides. 1985;36:75.
  17. Im SJ, Kim KN, Yun YG, Lee JC, Mun YJ, Kim JH, Woo WH. Effect of Radix Ginseng and Radix Trichosanthis on the melanogenesis. Biol Pharm Bull. 2003;26:849-53. https://doi.org/10.1248/bpb.26.849
  18. Iwase M, Yoshiba S, Uchid M, Takaoka S, Kurihara Y, Ito D, Hatori M, Shintani S. Enhanced susceptibility to apoptosis of oral squamous cell carcinoma cells subjected to combined treatment with anticancer drugs and phosphatidylinositol 3- kinase inhibitors. Int J Oncol. 2007;31:1141-7.
  19. Kim HM, Lee EH, Hong SH, Song HJ, Shin MK, Kim SH, Shin TY. Effect of Syzygium aromaticum extract on immediate hypersensitivity in rats. J Ethnopharmacol. 1998;60:125-31. https://doi.org/10.1016/S0378-8741(97)00143-8
  20. Kim HM, Lee EH, Kim CY, Chung JG, Kim SH, Lim JP, Shin TY. Antianaphylactic properties of eugenol. Pharmacol Res. 1997;36:475-80. https://doi.org/10.1006/phrs.1997.0256
  21. Kim HM. Yi JM, Lim KS. Magnoliae flos inhibits mast celldependent immediate-type allergic reactions. Pharmacol Res. 1999;39:107-11. https://doi.org/10.1006/phrs.1998.0414
  22. Kim JH, Bae HR, Park BS, Lee JM, Ahn HB, Rho JH, Yoo KW, Park WC, Rho SH, Yoon HS, Yoo YH. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystininduced apoptosis of retinal pigment epithelial cells. J Pharmacol Exp Ther. 2003;305:474-81. https://doi.org/10.1124/jpet.102.047811
  23. Kondo K, Yamasaki S, Inoue N, Suqie T, Teratani N, Kan T, Shimada Y. Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma. Surg Today. 2006;36:966-74. https://doi.org/10.1007/s00595-006-3295-5
  24. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today. 1997;18:44-51. https://doi.org/10.1016/S0167-5699(97)80014-X
  25. Lee KJ, Kim JY, Choi JH, Kim HG, Chung YC, Roh SH, Jeong HG. Inhibition of tumor invasion and metastasis by aqueous extract of the radix of Platycodon grandiflorum. Food Chem Toxicol. 2006;44:1890-6. https://doi.org/10.1016/j.fct.2006.06.009
  26. Lee SH, Ryu Jk, Lee KY, Woo SM, Park JK, Yoo JW, Kim YT, Yoo YB. Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. Cancer Lett. 2008;259:39-49. https://doi.org/10.1016/j.canlet.2007.09.015
  27. Mai Z, Blackbum GL, Zhou JR. Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. Mol Carcinog. 2007;46:534-42. https://doi.org/10.1002/mc.20300
  28. Markowitz K, Moynihan M, Liu M, Kim S. Biologic properties of eugenol and zinc oxide-eugenol. Oral Surg Oral Med Oral Pathol. 1992;73:729-37. https://doi.org/10.1016/0030-4220(92)90020-Q
  29. Marshansky V, Wang X, Bertrand R, Luo H, Duguid W, Chinnadurai G, Kanaan N, Vu MD, Wu J. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol. 2001;166:3130-42. https://doi.org/10.4049/jimmunol.166.5.3130
  30. Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer. 2006;106:1260-8. https://doi.org/10.1002/cncr.21731
  31. Na HJ, Jeong HJ, Bae H, Kim YB, Park ST, Yun YG, Kim HM. Tongkyutang inhibits mast cell-dependent allergic reactions and inflammatory cytokines secretion. Clin Chim Acta. 2002;319:35-41. https://doi.org/10.1016/S0009-8981(02)00011-6
  32. Orlowski RZ. The role of the ubiquitin-proteasome pathway in apoptosis. Cell Death Differ. 1999;6:303-13. https://doi.org/10.1038/sj.cdd.4400505
  33. Park HI, Jeong MH, Lim YJ, Park BS, Kim GC, Lee YM, Kim HM, Yoo KS, Yoo YH. Szygium aromaticum (L.) Merr. Et Perry (Myrtaceae) flower bud induces apoptosis of p815 mastocytoma cell line. Life Sci. 2001;69:553-66. https://doi.org/10.1016/S0024-3205(01)01140-7
  34. Pisano C, Vesci L, Foderà R, Ferrara FF, Rossi C, De Cesare M, Zuco V, Pratesi G, Supino R, Zunino F. Antitumor activity of the combination of synthetic retinoid ST1926 and cisplatin in ovarian carcinoma models. Ann Oncol. 2007;18:1500-5. https://doi.org/10.1093/annonc/mdm195
  35. Porter AG. Protein translocation in apoptosis. Trends Cell Biol. 1999;9:394-401. https://doi.org/10.1016/S0962-8924(99)01624-4
  36. Satoh K, Sakagami H, Yokoe I, Kochi M, Fujisawa S. Interaction between eugenol-related compounds and radicals. Anticancer Res. 1998;18:425-8.
  37. Seki K, Yoshikawa H, Shiiki K, Hamada Y, Akamatsu N, Tasaka K. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, 3 and -6 in osteosarcoma. Cancer Chemother Pharmacol. 2000;45:199-206. https://doi.org/10.1007/s002800050030
  38. Shibuya H, Kato Y, Saito M, Isobe T, Tsuboi R, Koga M, Toyota H, Mizuguchi J. Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins. Melanoma Research. 2003;13:457-64. https://doi.org/10.1097/00008390-200310000-00004
  39. Shin BK, Lee EH, Kim HM. suppression of L-histidine decarboxylase mRNA expression by methyleugenol. Biochem Biophys Res Commun. 1997;232:188-91. https://doi.org/10.1006/bbrc.1997.6260
  40. Song MQ, Zhu JS, Chen JL, Wamg L, Da W, Zhu L, Zhang WP. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells. World J Gastroenterol. 2007;13:1788-93. https://doi.org/10.3748/wjg.v13.i12.1788
  41. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397: 441-6. https://doi.org/10.1038/17135
  42. Suzuki Y, Sugiyama K, Furuta H. Eugenol-mediated superoxide generation and cytotoxicity in guinea pig neutrophils. Jpn J Pharmacol. 1985;39:381-6. https://doi.org/10.1254/jjp.39.381
  43. Vinall RL, Hwa k, Ghosh P, Pan CX, Lava PN Jr, de vere White RW. Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis. Clin Cancer Res. 2007;13: 6204-16. https://doi.org/10.1158/1078-0432.CCR-07-0600
  44. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem. 2000;75:2288-97.
  45. Wang G, Reed E, Li QQ. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). Oncol Rep. 2004;12:955-65.
  46. Williams GT. Programmed cell death: Apoptosis and oncogenesis. Cell. 1991;65:1097-8. https://doi.org/10.1016/0092-8674(91)90002-G
  47. Wright SE, Baron DA, Heffner JE. Intravenous eugenol causes hemorrhagic lung edema in rats: proposed oxidant mechanisms. J Lab Clin Med. 1995;125:257-64.
  48. Yuan J. Evolutionary conservation of a genetic pathway of programmed cell death. J Cell Biochem. 1996;60:4-11. https://doi.org/10.1002/(SICI)1097-4644(19960101)60:1<4::AID-JCB2>3.0.CO;2-1
  49. Yde CW, Issinqer OG. Enhancing cisplatin sensitivity in MCF- 7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. Int J Oncol. 2006;29:1397-404.
  50. Zhou H, Kato A, Yasuda H, Miyaji T, Fujigaki Y, Yamamoto T, Yonemura K, Hishida A. The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol. 2004;200:111-20. https://doi.org/10.1016/j.taap.2004.04.003
  51. Zhu YP. Materia Medica: Chemistry, Pharmacology and Application. 1st ed., Amsterdam, Harwood Academic Publishers. 1996;1-3.